Evoke Pharma, Inc. (EVOK)

Evoke Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4	4	9	18	68	39
Market Cap Growth	-18.58%	-60.81%	-50.12%	-73.62%	73.44%	-9.17%
Enterprise Value	-0	4	4	14	65	34
PE Ratio	-	-0.45	-1.09	-2.10	-5.18	-5.51
PS Ratio	0.72	0.68	3.57	11.10	2957.73	-
PB Ratio	1.25	-1.36	2.19	5.05	-21.18	8.96
P/FCF Ratio	-0.87	-0.70	-1.36	-1.45	-10.27	-6.81
P/OCF Ratio	-0.87	-0.70	-1.36	-1.45	-10.27	-6.81
EV/Sales Ratio	0.08	0.73	1.69	8.55	2835.09	-
EV/EBITDA Ratio	-0.07	-0.53	-0.55	-1.72	-5.00	-4.73
EV/EBIT Ratio	-0.07	-0.52	-0.55	-1.72	-5.00	-4.73
EV/FCF Ratio	-0.08	-0.76	-0.64	-1.12	-9.84	-5.85
Debt / Equity Ratio	1.43	-1.94	1.26	1.41	-1.63	0.03
Debt / EBITDA Ratio	-0.76	-0.70	-0.67	-0.62	-0.40	-0.02
Debt / FCF Ratio	-0.84	-1.00	-0.78	-0.41	-0.79	-0.02
Quick Ratio	1.25	0.56	6.33	6.72	1.07	2.81
Current Ratio	1.39	0.71	7.09	7.51	1.23	3.10
Asset Turnover	0.67	0.61	0.21	0.11	0.00	0
Interest Coverage	-13.22	-14.58	-15.45	-16.07	-115.42	-
Return on Equity (ROE)	-4897.70%	3951.50%	-175.50%	-154.50%	2031.60%	-150.20%
Return on Assets (ROA)	-78.40%	-91.80%	-67.60%	-57.80%	-180.90%	-110.80%
Return on Capital (ROIC)	-79.76%	-307.00%	-84.51%	-95.15%	-642.33%	-158.32%
Earnings Yield	-163.17%	-221.93%	-91.79%	-47.54%	-19.32%	-18.15%
FCF Yield	-135.80%	-141.97%	-73.62%	-68.78%	-9.74%	-14.68%
Buyback Yield / Dilution	-171.67%	-6.34%	-17.21%	-26.26%	-14.33%	-34.29%
Total Shareholder Return	-171.67%	-6.34%	-17.21%	-26.26%	-14.33%	-34.29%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).